3,495 Shares in Stryker Corporation $SYK Purchased by Bluebird Wealth Management LLC

Bluebird Wealth Management LLC purchased a new position in shares of Stryker Corporation (NYSE:SYK) during the fourth quarter, Holdings Channel reports. The firm purchased 3,495 shares of the medical technology company’s stock, valued at approximately $1,228,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of SYK. Corient Private Wealth LLC boosted its position in Stryker by 104.4% during the second quarter. Corient Private Wealth LLC now owns 2,245,841 shares of the medical technology company’s stock worth $887,525,000 after acquiring an additional 1,146,998 shares during the last quarter. Alliancebernstein L.P. boosted its position in Stryker by 13.3% during the third quarter. Alliancebernstein L.P. now owns 6,338,050 shares of the medical technology company’s stock worth $2,342,987,000 after acquiring an additional 741,542 shares during the last quarter. Strive Asset Management LLC acquired a new position in Stryker during the third quarter worth about $227,389,000. Credit Agricole S A acquired a new position in Stryker during the third quarter worth about $194,045,000. Finally, Pictet Asset Management Holding SA boosted its holdings in Stryker by 190.3% in the 4th quarter. Pictet Asset Management Holding SA now owns 466,256 shares of the medical technology company’s stock valued at $163,878,000 after purchasing an additional 305,640 shares during the last quarter. 77.09% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

SYK has been the topic of several recent analyst reports. Jefferies Financial Group reiterated a “buy” rating and issued a $465.00 target price on shares of Stryker in a report on Wednesday, March 4th. Piper Sandler reiterated an “overweight” rating on shares of Stryker in a report on Tuesday, January 27th. Weiss Ratings lowered shares of Stryker from a “hold (c+)” rating to a “hold (c)” rating in a report on Monday. Leerink Partners initiated coverage on shares of Stryker in a report on Monday, April 13th. They issued an “outperform” rating and a $410.00 target price on the stock. Finally, Evercore set a $355.00 target price on shares of Stryker in a report on Friday, May 1st. Sixteen equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $395.48.

Stryker Price Performance

Stryker stock opened at $292.13 on Thursday. The company’s 50 day simple moving average is $342.12 and its 200-day simple moving average is $355.73. The company has a market capitalization of $111.88 billion, a price-to-earnings ratio of 33.81, a price-to-earnings-growth ratio of 1.86 and a beta of 0.80. Stryker Corporation has a 1 year low of $289.91 and a 1 year high of $404.87. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.25 and a current ratio of 2.11.

Stryker (NYSE:SYK) last released its quarterly earnings results on Thursday, April 30th. The medical technology company reported $2.60 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.98 by ($0.38). The company had revenue of $6.02 billion during the quarter, compared to analysts’ expectations of $6.34 billion. Stryker had a net margin of 13.20% and a return on equity of 23.42%. Stryker’s revenue was up 2.6% on a year-over-year basis. During the same period last year, the firm posted $2.84 earnings per share. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. As a group, equities research analysts expect that Stryker Corporation will post 14.97 earnings per share for the current year.

Stryker Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.